(Q35314506)

7 August 2017

1 reference

title

Natural and synthetic antifibrinolytics in cardiac surgery (English)

1 reference

7 August 2017

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1373346

19 September 2022

author name string

J. F. Hardy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1373346

19 September 2022

J. Desroches

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1373346

19 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1373346

19 September 2022

publication date

1 April 1992

1 reference

Canadian Journal of Anaesthesia

7 August 2017

published in

1 reference

7 August 2017

volume

39

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

353-365

1 reference

Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits

7 August 2017

cites work

1 reference

12 December 2020

A critical reappraisal of the bleeding time

1 reference

12 December 2020

Platelet Activation and Aggregation during Cardiopulmonary Bypass

1 reference

12 December 2020

Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator

1 reference

12 December 2020

Periepicardial fibrinolytic activity: relation to cardiac bleeding

1 reference

12 December 2020

Natural proteinase inhibitors in extracorporeal circulation

1 reference

12 December 2020

Effect of intraoperative aprotinin administration on postoperative bleeding in patients undergoing cardiopulmonary bypass operation

1 reference

12 December 2020

Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation

1 reference

12 December 2020

The hemostatic response to open-heart operations

1 reference

12 December 2020

Clinical application of inhibitors of fibrinolysis

1 reference

12 December 2020

Prophylactic treatment of postperfusion bleeding using EACA.

1 reference

12 December 2020

Prophylactic tranexamic acid decreases bleeding after cardiac operations.

1 reference

12 December 2020

Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass

1 reference

12 December 2020

Epsilon-Aminocaproic Acid for Bleeding After Cardiopulmonary Bypass

1 reference

12 December 2020

Effect of aprotinin on need for blood transfusion after repeat open-heart surgery

1 reference

12 December 2020

Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.

1 reference

12 December 2020

On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or α2-antiplasmin

1 reference

12 December 2020

Blood Conservation Techniques and Platelet Function in Cardiac Surgery

1 reference

12 December 2020

Effect of aprotinin in adult respiratory distress syndrome

1 reference

12 December 2020

The pathogenesis and control of the hemorrhagic defect in open heart surgery

1 reference

12 December 2020

Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass

1 reference

12 December 2020

Platelet preservation during cardiopulmonary bypass with aprotinin

1 reference

12 December 2020

The Use of Epsilon-aminocaproic Acid to Reduce Bleeding during Cardiac Bypass in Children with Congenital Heart Disease

1 reference

12 December 2020

The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases

1 reference

12 December 2020

Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization

1 reference

12 December 2020

Mediastinal bleeding after cardiac surgery: etiologies, diagnostic considerations, and blood conservation methods

1 reference

12 December 2020

The effects of aprotinin on hemostatic function during cardiac surgery

1 reference

12 December 2020

Fibrinogen receptors in platelet adhesion to surfaces of extracorporeal circuit

1 reference

12 December 2020

Bleeding after cardiopulmonary bypass

1 reference

12 December 2020

Lillehei CW: Effect of epsilon aminocaproic acid upon blood loss following open-heart surgery: an analysis of 340 patients

1 reference

12 December 2020

Effect of antifibrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery

1 reference

12 December 2020

Invited letter concerning: aprotinin

1 reference

12 December 2020

Hemostasis changes during cardiopulmonary bypass surgery

1 reference

12 December 2020

Feasibility study of very high aprotinin dosage in polytrauma patients

1 reference

12 December 2020

Aprotinin, erythropoietin, and blood substitutes

1 reference

12 December 2020

Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acid

1 reference

12 December 2020

Aprotinin protects platelets against the initial effect of cardiopulmonary bypass

1 reference

12 December 2020

Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA

1 reference

12 December 2020

Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting

1 reference

12 December 2020

Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass

1 reference

12 December 2020

Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.

1 reference

12 December 2020

Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release

1 reference

12 December 2020

Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin.

1 reference

12 December 2020

Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).

1 reference

12 December 2020

Vasoactive agents and production of thrombosis during intravascular coagulation 1--comparative effects of norepinephrine in thrombin and adenosine diphosphate (ADP) treated rabbits

1 reference

12 December 2020

Reduction of blood transfusion requirement in open heart surgery by administration of high doses of aprotinin--preliminary results

1 reference

12 December 2020

Bleeding complications associated with cardiopulmonary bypass.

1 reference

12 December 2020

HEMOSTATIC MECHANISM IN EXTRACORPOREAL CIRCULATION

1 reference

12 December 2020

THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS

1 reference

12 December 2020

Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application--clinical experience in 152 cardiac surgical patients.

1 reference

12 December 2020

The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study

1 reference

12 December 2020

Reduced blood loss following open heart surgery with aprotinin (Trasylol) is associated with an increase in intraoperative activated clotting time (ACT).

1 reference

12 December 2020

Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery

1 reference

12 December 2020

High-dose aprotinin: hemostatic effects in open heart operations.

1 reference

12 December 2020

Aprotinin and thrombus formation on pulmonary artery catheters: a piece of the coagulation puzzle

1 reference

12 December 2020

Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass

1 reference

12 December 2020

Bleeding patterns after open-heart surgery

1 reference

12 December 2020

Serial use of aprotinin and incidence of allergic reactions

1 reference

12 December 2020

Increased anticoagulation during cardiopulmonary bypass by aprotinin.

1 reference

12 December 2020

Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions

1 reference

12 December 2020

The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group

1 reference

12 December 2020

Desmopressin and antifibrinolytics.

1 reference

12 December 2020

Thrombosis with epsilon aminocaproic acid therapy

1 reference

12 December 2020

Current status of antifibrinolytic drugs

1 reference

12 December 2020

The Treatment of Postperfusion Bleeding Using ε-Aminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate

1 reference

12 December 2020

Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo

1 reference

12 December 2020

Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. Effect of aprotinin in an experimental model

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03009046

1 reference

release_s66ih5zkvzdvjphsutun4hh4fm

7 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s66ih5zkvzdvjphsutun4hh4fm

24 November 2022

mapped directly with Wikidata item

1 reference